Basic Info.
Product Description
1,2,3-1h-triazole
cas no: 288-36-8
synonyms: 1,2,3-1h-triazole
 appearance: colorless transparent liquid
 molecular formula: c2h3n3
 molecular weight: 69.07
 melting point: 201-203 °c
 fusion point: ≥23-25 ºc
purity: ≥98.0%
 usage: as intermediate in the synthesis of tazobactam
Company Profile
| |
Business Type: |
Wuhan runder pharmda technology co.,ltd devoted to research and development, production and marketing for fine chemical products and chemical intermediates. we specialize in pharmaceutical intermediates, active pharmaceutical ingredients and other fine chemicals production, technology and service. |
| |
Comapany: |
Wuhan runder pharm technology co.,ltd |
| |
Year of Establishment: |
2008 |
| |
Address: |
Room no.2,seaview one road, er zhi gou, east and west lake area,wu han city |
| |
City: |
Wu han city |
| |
Zip/Postal: |
430040 |
| |
State: |
China |
| |
Country: |
China |
wuhan runder pharmda technology co.,ltd devoted to research and development, production
and marketing for fine chemical products and chemical intermediates. we specialize in pharmaceutical
intermediates, active pharmaceutical ingredients and other fine chemicals production, technology and
service.
wuhan runder pharmda technology co.,ltd established in wu han city, the most important
transportation junction center and industry base, relying on our strong r&d team and partnership with
wuhan scientific research institution, we have strong support for high technology fine chemicals in
advanced technology, quality guarantee and superior service. we committed to win win partnership, and actively expand and stretch long term value of products and partners, to achive
long-term strategic and mutually beneficial among domestic and foreign partners.
our company provides chemicals customized services. and we are experienced at production,
processing,detection of high purity chemical products, so that we can provide customized chemical
products upon your specifications , and provide cmo services for enterprises.
.
